查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402601

血管闭合装置市场：依产品类型、按通路、按孔尺寸、依最终用户、按地区

Vascular Closure Device Market, by Product Type, By Access, By Hole Size By End User and by Region
出版日期: | 出版商: Coherent Market Insights | 英文 233 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血管闭合装置的全球市场规模预计将从 2023 年的 12.838 亿美元增加到 2030 年的 19.432 亿美元，预测期内复合年增长率为 6.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 12.838 亿美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.10% 2030年市场规模预测 19.432 亿美元
图 1. 2023 年血管闭合装置的全球市场占有率（按地区划分）
血管闭合装置市场-IMG1

血管闭合装置有助于在血管造影术或血管成形术等心血管手术后密封动脉穿孔。它透过机械或生物手段促进自然凝血，有助于穿刺部位止血。随着全球介入性心臟病学和放射治疗的发展，血管闭合装置的全球使用量不断增加。与手动压迫方法相比，血管闭合装置可以改善患者舒适度、缩短住院时间并降低併发症率，这使得血管闭合装置对于血管通路部位的管理至关重要。

市场动态：

由于人口变化和技术进步等多种因素，全球血管闭合装置市场正经历显着成长。造成这种增长的一个主要因素是老年人口的增加，由于生理衰老，他们更容易患心血管疾病。随着老年人口的增加，心血管疾病的发生率也随之增加，导致诊断和治疗程序后对有效血管闭合装置的需求增加。同时，整个医疗保健产业向微创手术 (MIS) 的转变已经变得越来越明显。与传统开放性手术相比，MIS手术可降低感染风险、缩短住院时间并加速患者復原速度。血管闭合装置在这些手术中发挥重要作用，包括快速止血、减少行走时间和提高患者舒适度。

仪器技术的进步也至关重要，它可以使仪器更有效并降低术后併发症的风险。设计和材料的改进使得产品能够提供更好的密封性并与各种解剖形状和穿刺尺寸相容。另一方面，与这些先进设备相关的高成本可能会成为普及的障碍。某些医疗保健系统缺乏报销进一步加剧了这个问题，使患者难以获得这些技术。现有的替代方法可以实现止血，例如手动压迫，但它们通常会导致恢復时间更长并增加併发症的风险。

这个市场提供了庞大的商机，特别是在目前正在加强医疗保健和医疗基础设施投资的新兴国家。新型设备的持续开发具有巨大潜力，例如由生物分解性材料製成的设备，通常用于经导管主动脉瓣置换术术 (TAVR) 等复杂手术。总体而言，儘管成本和报销问题等挑战仍然存在，但血管闭合装置的优势，例如技术进步和对 MIS 需求的增加，可能会继续推动市场成长。

例如，2021 年 1 月，专注于提供创新医疗解决方案以促进更好患者治疗效果的医疗技术公司 Haemonetics Corporation 收购了私人公司.。我们已签署正式合同所以。

本研究的主要特点

  • 该报告对全球血管闭合器械市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球血管闭合装置市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球血管闭合装置市场报告满足该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
  • 透过用于分析全球血管闭合装置市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 老年人口增加
  • 血管成形术迅速增加
  • 心血管疾病盛行率增加
  • 微创手术需求增加
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球血管闭合装置市场 - 冠状冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球血管闭合装置市场，依产品类型，2023-2030

  • 被动血管闭合装置
  • 主动血管闭合装置
  • 体外止血装置

第六章 全球血管闭合装置市场，Access，2023-2030

  • 股骨
  • 径向

第 7 章 全球血管闭合装置市场（按孔尺寸），2023-2030 年

  • 小孔
  • 长孔

第 8 章全球血管闭合装置市场，依最终用户划分，2023-2030 年

  • 医院
  • 门诊手术中心
  • 其他的

第9章全球血管闭合装置市场，按地区，2023-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第10章竞争形势

  • Abbott
  • Cardiva Medical Inc.
  • Terumo Corporation
  • Johnson & Johnson Services Inc.
  • Braun SE
  • Biotronik SE & Co. KG
  • MicroPort Scientific Corporation
  • ConforMIS, Inc.
  • Medtronic
  • Transluminal Technologies LLC
  • Cardinal Health
  • Teleflex Incorporated
  • Vasorum Ltd.
  • Tricol Biomedical
  • Merit Medical Systems, Inc.
  • Stryker

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1330

The global vascular closure device market size is expected to reach US$ 1,943.2 Mn by 2030, from US$ 1,283.8 Mn in 2023, at a CAGR of 6.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,283.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.10% 2030 Value Projection: US$ 1,943.2 Mn
Figure 1. Global Vascular Closure Device Market Share (%), by Region, 2023
Vascular Closure Device Market - IMG1

Vascular closure devices help seal arterial punctures after a cardiovascular procedure such as angiography or angioplasty. They help stop bleeding at the puncture site by accelerating natural clotting through mechanical or biological means. The global usage of vascular closure devices has been increasing with growth in interventional cardiology and radiology procedures worldwide. Improved patient comfort, reduced hospital stay times, and lower complication rates compared to manual compression methods have made vascular closure devices an integral part of vascular access site management.

Market Dynamics:

The global vascular closure device market is growing substantially, propelled by a confluence of factors ranging from demographic shifts to technological progress. A significant contributor to this growth is the rising geriatric population which is more susceptible to cardiovascular diseases due to physiological aging. As the elderly population grows, so does the incidence of cardiovascular conditions, thereby increasing the demand for effective vascular closure devices following diagnostic and therapeutic procedures. Simultaneously, a notable shift towards minimally invasive surgeries (MIS) across the healthcare sector. MIS procedures reduce the risk of infection, shorten hospital stays, and speed up patient recovery times compared to traditional open surgeries. Vascular closure devices play a key role in these procedures by providing rapid hemostasis, reducing time to ambulation, and enhancing patient comfort.

Advancements in device technology have also been pivotal, leading to devices that offer greater efficacy and a reduced risk of post-procedure complications. Enhanced designs and materials have yielded products with improved sealing capabilities and compatibility with various anatomies and puncture sizes. On the other side of the spectrum, the high costs associated with these advanced devices can act as a barrier to their widespread adoption. The lack of reimbursement in certain healthcare systems further exacerbates this issue, making it challenging for patients to access these technologies. While existing alternatives for achieving hemostasis, such as manual compression, exist, they often come with longer recovery times and elevated risks of complications, thereby providing an opening for the adoption of advanced vascular closure devices.

The market is ripe with opportunities, especially within emerging economies that are currently witnessing increased healthcare investments and enhancements to their healthcare infrastructure. The significant potential in the ongoing development of novel devices, including those made from biodegradable materials, commonly used in complex procedures like transcatheter aortic valve replacement (TAVR).Overall, while challenges like cost and reimbursement issues persist, the benefits of vascular closure devices, including the advancements in technology and rising demands for MIS, are likely to continue to drive market growth.

For instance, in January 2021, Haemonetics Corporation, a medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., a manufacturer of vascular closure systems.

Key features of the study:

  • This report provides in-depth analysis of the global vascular closure device market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global vascular closure device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott, Cardiva Medical Inc., Terumo Corporation, Johnson & Johnson Services Inc., B. Braun SE, Biotronik SE & Co. KG, MicroPort Scientific Corporation, ConforMIS, Inc., Medtronic, Transluminal Technologies LLC, Cardinal Health, Teleflex Incorporated, Vasorum Ltd., Tricol Biomedical, Merit Medical Systems, Inc., Stryker
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global vascular closure device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular closure device market

Detailed Segmentation:

Global Vascular Closure Device Market

  • By Product Type
    • Passive Vascular Closure Devices
    • Active Vascular Closure Devices
    • External Hemostatic Devices
  • By Access
    • Femoral
    • Radial
  • By Hole Size
    • Small Hole
    • Large Hole
  • By End User
    • Hospitals
    • Ambulatory Surgery Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top companies in Global Vascular Closure Device Market:
    • Abbott
    • Cardiva Medical Inc.
    • Terumo Corporation
    • Johnson & Johnson Services Inc.
    • B.Braun SE
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • ConforMIS, Inc.
    • Medtronic
    • Transluminal Technologies LLC
    • Cardinal Health
    • Teleflex Incorporated
    • Vasorum Ltd.
    • Tricol Biomedical
    • Merit Medical Systems, Inc.
    • Stryker

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Vascular Closure Device Market, By Product Type
    • Vascular Closure Device Market, By Access
    • Vascular Closure Device Market, By Hole Size
    • Vascular Closure Device Market, By End User
    • Vascular Closure Device Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
  • Rising geriatric population
  • The proliferation of angioplasty procedures
  • The increasing prevalence of cardiovascular diseases incidence
  • Increasing demand for minimally invasive surgeries
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Vascular Closure Device Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Vascular Closure Device Market, By Product Type, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Passive Vascular Closure Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Active Vascular Closure Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • External Hemostatic Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Vascular Closure Device Market, By Access, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Femoral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Radial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Vascular Closure Device Market, By Hole Size, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Small Hole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Large Hole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Vascular Closure Device Market, By End User, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Ambulatory Surgery Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Global Vascular Closure Device Market, By Region, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Access, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Access, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Access, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Access, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Access, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Access, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

  • Abbott
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardiva Medical Inc.
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ConforMIS, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Transluminal Technologies LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cardinal Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teleflex Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Vasorum Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tricol Biomedical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merit Medical Systems, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Stryker
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us